☆ 4.5 Article

Effectiveness and Safety of Long-Term Dupilumab Treatment in Elderly Patients with Atopic Dermatitis: A Multicenter Real-Life Observational Study

AMERICAN JOURNAL OF CLINICAL DERMATOLOGY (2021)

Related references

Note: Only part of the references are listed.
Letter Dermatology

A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis

M. C. Fargnoli et al.

JOURNAL OF DERMATOLOGICAL TREATMENT (2022)

Add to Collection
Article Dermatology

Real-life experience on effectiveness and safety of dupilumab in adult patients with moderate-to-severe atopic dermatitis

M. C. Fargnoli et al.

Summary: A retrospective cohort study conducted in Italy showed that dupilumab significantly improved disease symptoms in adults with moderate-to-severe atopic dermatitis, including itch and sleep loss, with an acceptable safety profile.

JOURNAL OF DERMATOLOGICAL TREATMENT (2021)

Add to Collection
Letter Dermatology

Long-term effectiveness of dupilumab up to 52 weeks in atopic dermatitis in 253 adult patients

E. Nettis et al.

BRITISH JOURNAL OF DERMATOLOGY (2021)

Add to Collection
Article Dermatology

Dupilumab therapy of atopic dermatitis of the elderly: a multicentre, real-life study

C. Patruno et al.

Summary: This study retrospectively observed the efficacy and safety of dupilumab in treating severe atopic dermatitis in patients aged 65 and above. The results indicated that there were no significant differences in efficacy and safety of dupilumab between elderly patients and those aged 18-64, showing good efficacy and safety in treating atopic dermatitis.

JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2021)

Add to Collection
Letter Dermatology

Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study

Christine E. Jo et al.

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2020)

Add to Collection
Article Dermatology

Efficacy and safety of dupilumab in atopic dermatitis in elderly patients: a retrospective study

M. Napolitano et al.

CLINICAL AND EXPERIMENTAL DERMATOLOGY (2020)

Add to Collection
Article Dermatology

Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis A Randomized Clinical Trial

Margitta Worm et al.

JAMA DERMATOLOGY (2020)

Add to Collection
Letter Dermatology

Treatment of moderate-to-severe atopic dermatitis with dupilumab in real clinical practice: a multicentre, retrospective case series

J. C. Armario-Hita et al.

BRITISH JOURNAL OF DERMATOLOGY (2019)

Add to Collection
Article Dermatology

Fifty-two week follow-up safety and effectiveness results of dupilumab treatment of moderate-to-severe atopic dermatitis from a retrospective, multicentric series

Ricardo Ruiz-Villaverde et al.

DERMATOLOGIC THERAPY (2019)

Add to Collection
Article Medicine, General & Internal

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt et al.

LANCET (2017)

Add to Collection
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.